Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Uncommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-life Practice in First Line Setting

NCT05421936 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT05421936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05421936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Uncommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-life Practice in First Line Setting
Lead sponsor
Sheba Medical Center
Phase
Observational
Overall status
Suspended
Start date
September 27, 2020
Completion date
September 30, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung, genes, erbb-1